Johanna Mercier Gilead Sciences, Inc. (GILD) insider trading activity

Johanna Mercier is Chief Commercial Officer of GILEAD SCIENCES, INC.. Currently has a direct ownership of 106,221 shares of GILD, which is worth approximately $13.2 Million. The most recent transaction as insider was on Dec 15, 2025, when has been sold 3,000 shares (Common Stock) at a price of $122.0 per share, resulting in proceeds of $366,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 106K

6.16% 3M change

41.36% 12M change

Total Value Held $13.2 Million

Johanna Mercier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2025	SELL Open market or private sale	$366,000 $122.0 p/Share	3,000 Reduced 2.75%	106,221 Common Stock
Dec 10 2025	SELL Payment of exercise price or tax liability	$220,110 $121.34 p/Share	1,814 Reduced 1.63%	109,221 Common Stock
Dec 10 2025	BUY Exercise of conversion of derivative security	-	3,842 Added 3.34%	111,035 Common Stock
Nov 17 2025	SELL Open market or private sale	$3,529,400 $126.05 p/Share	28,000 Reduced 20.71%	107,193 Common Stock
Nov 17 2025	BUY Exercise of conversion of derivative security	$1,666,000 $66.64 p/Share	25,000 Added 15.61%	135,193 Common Stock
Oct 15 2025	SELL Open market or private sale	$354,240 $118.08 p/Share	3,000 Reduced 2.65%	110,193 Common Stock
Sep 15 2025	SELL Open market or private sale	$340,710 $113.57 p/Share	3,000 Reduced 2.58%	113,193 Common Stock

Sep 10 2025	SELL Payment of exercise price or tax liability	$209,639 $115.25 p/Share	1,819 Reduced 1.54%	116,193 Common Stock
Sep 10 2025	BUY Exercise of conversion of derivative security	-	3,844 Added 3.15%	118,012 Common Stock
Aug 15 2025	SELL Open market or private sale	$3,324,720 $118.74 p/Share	28,000 Reduced 19.7%	114,168 Common Stock
Aug 15 2025	BUY Exercise of conversion of derivative security	$1,666,000 $66.64 p/Share	25,000 Added 17.5%	117,868 Common Stock
Jul 15 2025	SELL Open market or private sale	$333,090 $111.03 p/Share	3,000 Reduced 2.5%	117,168 Common Stock
Jun 16 2025	SELL Open market or private sale	$330,510 $110.17 p/Share	3,000 Reduced 2.44%	120,168 Common Stock
Jun 10 2025	SELL Payment of exercise price or tax liability	$201,134 $110.09 p/Share	1,827 Reduced 1.46%	123,168 Common Stock
Jun 10 2025	BUY Exercise of conversion of derivative security	-	3,843 Added 2.98%	124,995 Common Stock
May 22 2025	SELL Open market or private sale	$3,010,560 $107.52 p/Share	28,000 Reduced 18.77%	121,152 Common Stock
May 22 2025	BUY Exercise of conversion of derivative security	$1,666,000 $66.64 p/Share	25,000 Added 15.47%	136,652 Common Stock
Mar 10 2025	SELL Payment of exercise price or tax liability	$457,939 $117.21 p/Share	3,907 Reduced 3.05%	124,152 Common Stock
Mar 10 2025	BUY Exercise of conversion of derivative security	-	8,080 Added 5.94%	128,059 Common Stock
Feb 04 2025	SELL Payment of exercise price or tax liability	$4,474,811 $97.99 p/Share	45,666 Reduced 27.57%	119,979 Common Stock
Feb 04 2025	BUY Grant, award, or other acquisition	-	90,505 Added 35.33%	165,645 Common Stock
Dec 10 2024	SELL Payment of exercise price or tax liability	$160,579 $92.34 p/Share	1,739 Reduced 2.26%	75,140 Common Stock
Dec 10 2024	BUY Exercise of conversion of derivative security	-	3,752 Added 4.65%	76,879 Common Stock
Nov 06 2024	SELL Open market or private sale	$456,400 $91.28 p/Share	5,000 Reduced 6.4%	73,127 Common Stock
Sep 12 2024	SELL Open market or private sale	$2,458,355 $83.74 p/Share	29,357 Reduced 27.31%	78,127 Common Stock

Also insider at

NBIX

NEUROCRINE BIOSCIENCES INC Healthcare

Director

Johanna Mercier

Chief Commercial Officer

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Value

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

Operation

Value

Type

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD

Account